West Pharmaceutical Services (WST) Current Deferred Tax Assets (2009 - 2015)

West Pharmaceutical Services (WST) has reported Current Deferred Tax Assets for 7 consecutive years, with $8.3 million the latest figure, recorded in Q3 2015.

• Quarterly Current Deferred Tax Assets fell 54.89% year-over-year to $8.3 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $8.3 million (down 54.89% YoY) and the FY2014 annual result came in at $7.8 million, down 50.94% from the prior year.
• Current Deferred Tax Assets improved to $8.3 million in Q3 2015 per WST's latest filing, from $8.2 million in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for WST reached as high as $18.4 million in Q3 2014 and fell as low as $7.4 million in Q2 2012.
• A 5-year average of $10.7 million and a median of $9.1 million in 2013 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2013 — Current Deferred Tax Assets jumped 106.49% — and 2015, when it sank 54.89%.
• Year by year, Current Deferred Tax Assets stood at $7.9 million in 2011, then fell by 2.53% to $7.7 million in 2012, then jumped by 106.49% to $15.9 million in 2013, then plunged by 50.94% to $7.8 million in 2014, then climbed by 6.41% to $8.3 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $8.3 million, $8.2 million, and $8.7 million for Q3 2015, Q2 2015, and Q1 2015 respectively.